22 July 2019

Allen & Gledhill advised PanAsia Health Limited (“PanAsia Health”), which is indirectly controlled by EQT Mid Market Asia III GP B.V., acting in its capacity as general partner of EQT Mid Market Asia III Limited Partnership (“EQT”), and Nam See Investment (Pte) Ltd. (“Nam See Investment”), the founding family and substantial shareholder of Health Management International Ltd (“HMI”), as transaction counsel, on the S$611 million proposed acquisition of all shares in HMI by way of a scheme of arrangement.

Advising PanAsia Health and EQT were Allen & Gledhill Partners Christopher Koh and Wong Yi Jia.

Advising Nam See Investment were Allen & Gledhill Partners Song Su-Min and Chiam Tao Koon.

More

A&G News 17 April 2025

Allen & Gledhill named National Law Firm of the Year (Singapore) at IFLR Asia-Pacific Awards 2025

Read more

A&G News 14 April 2025

Allen & Gledhill recognised among world’s top international arbitration practices

Read more